Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
J05AD01
CAS registry number (Chemical Abstracts Service)
0063585-09-1
Chemical Formula
C-Na3-O5-P
Molecular Weight
191
Therapeutic Category
Antiviral agent
Chemical Name
Phosphinecarboxylic acid, dihydroxy-, oxide, trisodium salt
Foreign Names
- Foscarnetum Natricum (Latin)
- Foscarnet natrium (German)
- Foscarnet sodique (French)
- Foscarnet sodico (Spanish)
Generic Names
- Foscarnet sodico (OS: DCIT)
- Foscarnet sodique (OS: DCF)
- Foscarnet Sodium (OS: USAN, BAN)
- A 29622 (IS)
- EHB 776 (IS)
- PFA (IS)
- Phosphonoformic Acid Trisodium (IS)
- Trisodium Carboxyphosphate (IS)
- Trisodium Phosphonoformate (IS)
- Foscarnet sodium hydrate (OS: JAN)
- Foscarnet sodique hexahydraté (PH: Ph. Eur. 6)
- Foscarnet Sodium (PH: BP 2010, USP 32)
- Foscarnet Sodium Hexahydrate (PH: Ph. Eur. 6)
- Foscarnet-Natrium-Hexahydrat (PH: Ph. Eur. 6)
- Foscarnetum natricum hexahydricum (PH: Ph. Eur. 6)
Brand Names
- Foscarnet Dosa
Dosa, Argentina - Foscarnet Sodium Injection
Hospira, United States; PharmaForce, United States - Foscavir
AstraZeneca, Spain; AstraZeneca, Italy; IFET, Greece - Foscarnet Gemepe
Gemepe, Argentina - Foscavir
AstraZeneca, Australia; AstraZeneca, Belgium; AstraZeneca, Switzerland; AstraZeneca, Germany; AstraZeneca, France; AstraZeneca, United Kingdom; AstraZeneca, Israel; AstraZeneca, Japan; AstraZeneca, Luxembourg; AstraZeneca, Netherlands; AstraZeneca, New Zealand; AstraZeneca, Portugal; AstraZeneca, United States - Triapten
Riemser, Germany
International Drug Name Search
Glossary
| BAN | British Approved Name |
| DCF | Dénomination Commune Française |
| DCIT | Denominazione Comune Italiana |
| IS | Inofficial Synonym |
| JAN | Japanese Accepted Name |
| OS | Official Synonym |
| PH | Pharmacopoeia Name |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| USAN | United States Adopted Name |
Click for further information on drug naming conventions and International Nonproprietary Names.
No comments:
Post a Comment